Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?
Pozzi S, Scomparin A, Israeli Dangoor S, Rodriguez Ajamil D, Ofek P, Neufeld L, Krivitsky A, Vaskovich-Koubi D, Kleiner R, Dey P, Koshrovski-Michael S, Reisman N, Satchi-Fainaro R.
Pozzi S, et al. Among authors: krivitsky a.
Adv Drug Deliv Rev. 2021 Aug;175:113760. doi: 10.1016/j.addr.2021.04.001. Epub 2021 Apr 7.
Adv Drug Deliv Rev. 2021.
PMID: 33838208
Review.